Wirkstoffe & Arzneimittelsicherheit

Nebenwirkungen · Desloratadine Actavis

Desloratadine Actavis 5 mg film-coated tablets · Abschnitt 4.8 · PDF-Seite 4

HOS-215624 · Präparat HOS-155480

System Organ Class Adverse reactions seen with Frequency desloratadine Metabolism and Not known Increased appetite nutrition disorders Psychiatric disorders Very rare Hallucinations Not known Abnormal behaviour*, aggression*, depressed mood Nervous system Common Headache disorders Very rare Dizziness, somnolence, insomnia, psychomotor hyperactivity, seizures Eye disorders Not known Eye dryness Cardiac disorders Very rare Tachycardia, palpitations Not known QT prolongation* Gastrointestinal Common Dry mouth disorders Very rare Abdominal pain, nausea, vomiting, dyspepsia, diarrhoea Hepatobiliary disorders Very rare Elevations of liver enzymes, increased bilirubin, hepatitis Not known Jaundice Skin and subcutaneous Not known Photosensitivity tissue disorders Musculoskeletal and Very rare Myalgia connective tissue disorders General disorders and Common Fatigue administration site Very rare Hypersensitivity reactions (such as conditions anaphylaxis, angioedema, dyspnoea, pruritus, rash, and urticaria) Not known Asthenia Investigations Not known Weight increased * Undesirable effects reported during the post-marketing period also in paediatric patients.

Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.